<DOC>
	<DOCNO>NCT01674907</DOCNO>
	<brief_summary>This observational study evaluate use clinical practice efficacy Avastin ( bevacizumab ) patient metastatic colorectal cancer receive prior chemotherapy treatment metastatic setting . Patients treat physician decide initiate therapy Avastin follow 10 month .</brief_summary>
	<brief_title>An Observational Study Avastin ( Bevacizumab ) First Line Patients With Metastatic Colorectal Cancer ( AVANiS )</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Adult patient , &gt; /= 18 year age Histologically confirm metastatic colorectal cancer without prior chemotherapy metastatic setting Contraindications Avastin accord locally approve package insert ( version 7 April 2006 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>